{
    "eid": "2-s2.0-85051119071",
    "title": "CYP2D6 genotype analysis of a Thai population: Platform comparison",
    "cover-date": "2018-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Genetics",
            "@code": "1311",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "AmpliChip CYP450 test",
        "CYP2D6",
        "Luminex xTAG\u00ae",
        "MassARRAY\u00ae",
        "TaqMan\u00ae"
    ],
    "authors": [
        "Monpat Chamnanphon",
        "Andrea Gaedigk",
        "Natchaya Vanwong",
        "Nopphadol Nuntamool",
        "Yaowaluck Hongkaew",
        "Apichaya Puangpetch",
        "Chonlaphat Sukasem"
    ],
    "citedby-count": 11,
    "ref-count": 52,
    "ref-list": [
        "Pharmacogenomics and individualized drug therapy",
        "Pharmacogenetics of cytochrome P450 and its applications in drug therapy: The past, present and future",
        "Importance of CYP2D6 genotype/activity testing and applications",
        "Chromosomal assignment of human cytochrome P-450 (debrisoquine/sparteine type) to chromosome 22",
        "The human debrisoquine 4-hydroxylase (CYP2D) locus: Sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene",
        "Applications of CYP450 testing in the clinical setting",
        "Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation",
        "Characterization of a complex CYP2D6 genotype that caused an AmpliChip CYP450 Test no-call in the clinical setting",
        "Pharmacogenetics: Potential for individualized drug therapy through genetics",
        "CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure",
        "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and tamoxifen therapy",
        "Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update",
        "Association of CYP2D6 and CYP2C19 polymorphisms and disease-free survival of Thai post-menopausal breast cancer patients who received adjuvant tamoxifen",
        "Impact of CYP2D6 polymorphisms on tamoxifen responses of women with breast cancer: A microarray-based study in Thailand",
        "Combination of multiplex PCR and DHPLC-based strategy for CYP2D6 genotyping scheme in Thais",
        "Chapter 15-Pharmacogenetics and Pharmacogenomics A2-Ginsburg",
        "The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the human cytochrome P450 (CYP) allele nomenclature database",
        "In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles",
        "The CYP2D6 activity score: Translating genotype information into a qualitative measure of phenotype",
        "Functional characterization of CYP2D6 enhancer polymorphisms",
        "Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations",
        "Worldwide distribution of cytochrome P450 alleles: A meta-analysis of population-scale sequencing projects",
        "Prediction of CYP2D6 phenotype from genotype across world populations",
        "The AmpliChip CYP450 test: Cytochrome P450 2D6 genotype assessment and phenotype prediction",
        "Differential quantification of CYP2D6 gene copy number by four different quantitative real-time PCR assays",
        "CYP2D6 genotyping for functional-gene dosage analysis by allele copy number detection",
        "Allelic distributions of CYP2D6 gene copy number variation in the eastern Han Chinese population",
        "Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels",
        "Introduction of the AmpliChip CYP450 test to a South African cohort: A platform comparative prospective cohort study",
        "Pharmacogenetics in American Indian populations: Analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes",
        "SNP genotyping using TaqMan technology: The CYP2D617 assay conundrum",
        "Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: Characterization of gene duplication events",
        "Genetic variations of human CYP2D6 in the Chinese Han population",
        "AmpliChip CYP450 GeneChip: A new gene chip that allows rapid and accurate CYP2D6 genotyping",
        "Complexities of CYP2D6 gene analysis and interpretation",
        "CYP2D7-2D6 hybrid tandems: Identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction",
        "Identification of novel CYP2D7-2D6 hybrids: Non-functional and functional variants",
        "CYP2D6, SULT1A1 and UGT2B17 copy number variation: Quantitative detection by multiplex PCR",
        "Frequency of CYP2D6 alleles including structural variants in the United States",
        "CYP2D636 gene arrangements within the CYP2D6 locus: Association of CYP2D636 with poor metabolizer status",
        "CYP2D6 and CYP2C19 in Papua New Guinea: High frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess",
        "Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: A GeT-RM and association for molecular pathology collaborative project",
        "Allele drop out conferred by a frequent CYP2D6 genetic variation for commonly used CYP2D63 genotyping assays",
        "Resolution of a clinical AmpliChip CYP450 Test no call: Discovery and characterization of novel CYP2D61 haplotypes",
        "Detection and characterization of the CYP2D69x2 gene duplication in two Spanish populations: Resolution of AmpliChip CYP450 test no-calls",
        "Impact of pharmacogenetic markers of CYP2D6 and DRD2 on prolactin response in risperidone-treated Thai children and adolescents with autism spectrum disorders",
        "CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients",
        "Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients",
        "Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kansas City",
            "@id": "60007056",
            "affilname": "University of Missouri-Kansas City",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007056",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Chiangmai",
            "@id": "60006387",
            "affilname": "Payap University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006387",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Thailand Research Fund"
    ]
}